Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Postmenopausal Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03810625
What this trial is testing

Food Effect Study of D-0502 Tablet in Healthy Volunteers

Who this might be right for
Breast Cancer
InventisBio Co., Ltd 14
Large-scale testing (Phase 3)Study completedNCT03974100
What this trial is testing

Study Investigating PK, PD, Efficacy, Safety, and Immunogenicity of Biosimilar Denosumab (GP2411) in Patients With Postmenopausal Osteoporosis

Who this might be right for
Postmenopausal Women With Osteoporosis
Sandoz 527
Not applicableEnded earlyNCT05440734
What this trial is testing

Exogenous Melatonin in Postmenopausal Women with Insomnia

Who this might be right for
Insomnia
Douglas Mental Health University Institute 6
Not applicableUnknownNCT04867109
What this trial is testing

HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding

Who this might be right for
Endometrial NeoplasmsPostmenopauseUterine Hemorrhage+2 more
Nantes University Hospital 100
Testing effectiveness (Phase 2)Ended earlyNCT01528345
What this trial is testing

Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 97
Not applicableStudy completedNCT02304757
What this trial is testing

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Who this might be right for
Differentiated Thyroid CancerOsteoporosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 142
Testing effectiveness (Phase 2)WithdrawnNCT03532087
What this trial is testing

Study to Identify the Impact of Denosumab on the Immune System in Patients With HER2 Negative Breast Cancer

Who this might be right for
Breast Neoplasms
Borstkanker Onderzoek Groep
Large-scale testing (Phase 3)Study completedNCT00075855
What this trial is testing

Low-Dose Testosterone in Improving Libido in Postmenopausal Female Cancer Survivors

Who this might be right for
Cancer SurvivorSexual DysfunctionSexuality and Reproductive Issues+1 more
Alliance for Clinical Trials in Oncology 150
Large-scale testing (Phase 3)Study completedNCT00944918
What this trial is testing

Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)

Who this might be right for
Progression-free Survival
AstraZeneca 25
Not applicableNo Longer AvailableNCT05108740
What this trial is testing

MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer

Who this might be right for
Advanced Hormone Receptor Positive (HR+) Breast Cancer
Novartis Pharmaceuticals
Not applicableStudy completedNCT04492540
What this trial is testing

Response of Sex Hormones and Different Functions to Exercise and Diet in Elderly Women

Who this might be right for
Cognitive DeclinePostmenopausal Disorder
Cairo University 60
Not applicableLooking for participantsNCT05000515
What this trial is testing

Inspiratory Muscle Strength Training for Lowering Blood Pressure and Improving Endothelial Function in Postmenopausal Women: Comparison With "Standard of Care" Aerobic Exercise

Who this might be right for
AgingBlood PressureEndothelial Dysfunction+1 more
University of Colorado, Boulder 90
Not applicableStudy completedNCT05332626
What this trial is testing

Lactobacillus Acidophilus and Postmenopausal Women

Who this might be right for
Bone LossPost Menopausal OsteoporosisMineralization
Poznan University of Life Sciences 90
Early research (Phase 1)Study completedNCT00099008
What this trial is testing

Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women

Who this might be right for
Breast CancerEndometrial Cancer
UNC Lineberger Comprehensive Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT00171340
What this trial is testing

Zoledronic Acid in the Prevention of Cancer Treatment Related Bone Loss in Postmenopausal Women Receiving Letrozole for Breast Cancer.

Who this might be right for
Bone LossBreast Cancer
Novartis Pharmaceuticals 1,065
Not applicableLooking for participantsNCT04893226
What this trial is testing

Circadian Rhythms in Postmenopausal Women

Who this might be right for
Metabolic SyndromePostmenopausal Symptoms
Julie Pendergast 164
Not applicableActive Not RecruitingNCT02822378
What this trial is testing

Dried Plums and Bone Health in Postmenopausal Women

Who this might be right for
Postmenopausal Osteoporosis
Penn State University 322
Testing effectiveness (Phase 2)Ended earlyNCT01234532
What this trial is testing

Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery

Who this might be right for
Estrogen Receptor-negative Breast CancerHER2-negative Breast CancerProgesterone Receptor-negative Breast Cancer+4 more
University of Maryland, Baltimore 5
Not applicableStudy completedNCT00515593
What this trial is testing

PROPOSE Quality - PReOtact in Postmenopausal OStEoporosis - Quality of Life Study (FP-004-DE)

Who this might be right for
PostmenopauseOsteoporosis
Nycomed 110
Large-scale testing (Phase 3)Study completedNCT01160211
What this trial is testing

Compare the Safety and Efficacy of an Aromatase Inhibitor in Combination With Lapatinib, Trastuzumab or Both for the Treatment of Hormone Receptor Positive, HER2+ Metastatic Breast Cancer

Who this might be right for
Neoplasms, Breast
Novartis Pharmaceuticals 369
Next Page